Mutschler 2022 MitoFit: Difference between revisions
No edit summary |
No edit summary |
||
| (11 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{MitoFit page name}} | |||
{{Publication | {{Publication | ||
|title=Mutschler R (2022) Membranes as therapeutic targets - liposomes as therapeutic options | |title=Mutschler R (2022) Membranes as therapeutic targets - liposomes as therapeutic options. https://doi.org/10.26124/mitofit:2022-0010 | ||
|info=[[File:MitoFit Preprints pdf.png|left|160px|link=|MitoFit pdf]] [ Membranes as therapeutic targets - liposomes as therapeutic options]<br/> | |info=MitoFit Preprints 2022.10. [[File:MitoFit Preprints pdf.png|left|160px|link=https://wiki.oroboros.at/images/4/42/Mutschler_2022_MitoFit.pdf|MitoFit pdf]] [https://wiki.oroboros.at/images/4/42/Mutschler_2022_MitoFit.pdf Membranes as therapeutic targets - liposomes as therapeutic options]<br/> | ||
|authors=Mutschler Rainer | |authors=Mutschler Rainer | ||
|year=2022 | |year=2022 | ||
|journal=MitoFit Prep | |journal=MitoFit Prep | ||
|abstract=Damaged or chemically altered membranes are highly likely to play a central role at the molecular level in many chronic and acute diseases as well as in aging. Damage is often related to inflammatory processes that release large amounts of radical oxygen species (ROS). For several years, membrane replacement has been investigated as a therapeutic option for various diseases. Furthermore, liposomes represent potentially valuable tools for this purpose to force the integration of membrane material into the body's own tissue. Unfortunately, however, this method has not yet arrived in practice. Therefore, we have made our own efforts to establish membrane replacement in our practice, including the therapeutic use of liposomal products of high quality. Here we report on two successfully treated cases. <br><br> | |abstract=Damaged or chemically altered membranes are highly likely to play a central role at the molecular level in many chronic and acute diseases as well as in aging. Damage is often related to inflammatory processes that release large amounts of radical oxygen species ([[ROS]]). For several years, membrane replacement has been investigated as a therapeutic option for various diseases. Furthermore, liposomes represent potentially valuable tools for this purpose to force the integration of membrane material into the body's own tissue. Unfortunately, however, this method has not yet arrived in practice. Therefore, we have made our own efforts to establish membrane replacement in our practice, including the therapeutic use of liposomal products of high quality. Here we report on two successfully treated cases. <br><br> | ||
|keywords=membranes, liposomes, phospholipids, | |keywords=membranes, liposomes, phospholipids, phosphatidylcholine, membrane replacement therapy, liposomal formulations, mitochondria, adducts, detoxification | ||
|editor=Tindle-Solomon L | |editor=Tindle-Solomon L | ||
}} | }} | ||
{{Labeling | {{Labeling | ||
|area=Patients | |area=Patients | ||
| Line 14: | Line 16: | ||
|injuries=Oxidative stress;RONS | |injuries=Oxidative stress;RONS | ||
|organism=Human | |organism=Human | ||
}} | }} | ||
Latest revision as of 07:53, 8 January 2023
Mutschler 2022 MitoFit
| Mutschler R (2022) Membranes as therapeutic targets - liposomes as therapeutic options. https://doi.org/10.26124/mitofit:2022-0010 |
» MitoFit Preprints 2022.10.
Membranes as therapeutic targets - liposomes as therapeutic options
Mutschler Rainer (2022) MitoFit Prep
Abstract: Damaged or chemically altered membranes are highly likely to play a central role at the molecular level in many chronic and acute diseases as well as in aging. Damage is often related to inflammatory processes that release large amounts of radical oxygen species (ROS). For several years, membrane replacement has been investigated as a therapeutic option for various diseases. Furthermore, liposomes represent potentially valuable tools for this purpose to force the integration of membrane material into the body's own tissue. Unfortunately, however, this method has not yet arrived in practice. Therefore, we have made our own efforts to establish membrane replacement in our practice, including the therapeutic use of liposomal products of high quality. Here we report on two successfully treated cases.
• Keywords: membranes, liposomes, phospholipids, phosphatidylcholine, membrane replacement therapy, liposomal formulations, mitochondria, adducts, detoxification
• Bioblast editor: Tindle-Solomon L
Labels: MiParea: Patients Pathology: Inherited, Parkinson's Stress:Oxidative stress;RONS Organism: Human
